rc_oncneph Profile Banner
Raad Chowdhury, MD, FASN Profile
Raad Chowdhury, MD, FASN

@rc_oncneph

Followers
1K
Following
4K
Media
208
Statuses
2K

Medical Dir of Oncnph @bwhkidney @danafarber @harvardmed APD= Mass Gen Brigham Renal Fellowship @MGBkidneys VP @onconephsociety via @upmc + @mayoclinicneph

Boston, MA
Joined April 2019
Don't wanna be here? Send us removal request.
@rc_oncneph
Raad Chowdhury, MD, FASN
1 hour
We brought together some of the Onconephrology leaders from around the 🌎 @onconephsociety
0
1
2
@VincentRK
Vincent Rajkumar
9 hours
Daratumumab is now FDA and EU approved for treatment of high risk smoldering myeloma. It is recommended level 1 by NCCN. My thoughts: In the AQUILA randomized trial, daratumumab: -Prolonged time to active myeloma -Prolonged time to end organ damage -Delayed time to needing
3
12
43
@HerrmannMd
Sandra Herrmann MD, FASN
10 hours
Fantastic onconephrology session! Thanks to all the speakers and to everyone who attended! KidneyWk @onconephsociety @asnpublications @JayaKala11 @Nephronette @onconeph @SiskindLeah
0
9
30
@rc_oncneph
Raad Chowdhury, MD, FASN
14 hours
The Bo-STONE-ians @MGBKidneys headed to @ASNKidney FIT bowl finals against @hopkinsneph Proud of all these excellent fellows... future of Nephrology is 🌞 #asnkidneywk2025
0
0
5
@rc_oncneph
Raad Chowdhury, MD, FASN
1 day
Always a blast hanging with @glomcon Congrats to the Glomcon leadership for being innovative and transformative in teaching kidney medicine across the world! #asnkidneywk2025 @ASNKidney @SaynaNorouzi @BetterCallSeeth @AbdullahJalalMD @Nephro_Sparks @kkalra_22 @PaulHannaMD
1
3
26
@rc_oncneph
Raad Chowdhury, MD, FASN
1 day
Another year Moderating the ASN Kidney STARS career guidance panel. We have experts from peds-neph, transplant, private practice, and onconeph. A true testament to the Renaissance thats happening in Nephrology. @ASNKidney #asnkidneywk2025
0
2
17
@rc_oncneph
Raad Chowdhury, MD, FASN
1 day
The Bo-STONE-ians are advancing to the semi finals @ASNKidney FIT Bowl on friday. We appreciate all the support from faculty and alumni that stopped by. @MGBKidneys #asnkidneywk2025
1
1
22
@rc_oncneph
Raad Chowdhury, MD, FASN
2 days
Happening now #ASN FIT BOWL @MGBKidneys @ASNKidney #asnkidneywk2025 So excited for them!
0
0
13
@rc_oncneph
Raad Chowdhury, MD, FASN
2 days
Its become our annual mentor + mentee dinner at @ASNKidney #asnkidneywk2025 Fine wine, aged bourbon, endless discussions, and closing out a restaurant with Prof. Leung #Onconephrology @onconephsociety
2
1
35
@rc_oncneph
Raad Chowdhury, MD, FASN
2 days
My first training program directors meeting @ASNKidney #asnkidneywk2025 Honored to be part of this fraternity.. great discussions with other PDs , my former pds, and division chiefs.
0
0
13
@rc_oncneph
Raad Chowdhury, MD, FASN
3 days
5am Sapphire lounge diaries... on the way to #asnkidneywk2025 @BetterCallSeeth @MGBKidneys
0
0
28
@rc_oncneph
Raad Chowdhury, MD, FASN
5 days
Introducing our Mass Gen Brigham Renal FIT BOWL team for ASN: #kidneywk2025 Dr. Alshith Doddi (Sonny) Dr. Ashima Chadha Dr. Patrick Hofmann Dr. Ivan Cancarevic Missing faculty mentor Dr. Annie Liu @therealannieliu As APD: cant be more proud and excited for this week!
0
0
15
@rc_oncneph
Raad Chowdhury, MD, FASN
5 days
Highly endorse!
@SaynaNorouzi
Sayna Norouzi, MD, FASN
15 days
Registration is OPEN for our 3rd Annual Rare Kidney Disease Conference! 🎉 Check out our incredible faculty lineup!! we can’t wait! 😍 #RareKidney #Nephrology #MedEd For travel grants/Registration discount; DM me. 🫶🏻 https://t.co/gxJTB7lPj4 @rahaai @LLUHealth
1
2
4
@AnandVaidya17
Anand Vaidya
2 months
To accompany the new ACC/AHA BP guidelines, a practical guide on how to test for Primary Aldosteronism: now recommended for most people with hypertension. https://t.co/a0FTNTx1Wh
4
95
263
@VincentRK
Vincent Rajkumar
13 days
One of the main goals of our review article in @NEJM on MGUS was to provide clear clarifications on the concept of “monoclonal gammopathy of clinical significance” (MGCS). It’s all very confusing in the literature and can cause problems for patients if we are not totally clear of
Tweet card summary image
nejm.org
MGUS is a common, asymptomatic plasma-cell disorder in older adults that can progress to cancer or systemic illness. Diagnosis warrants follow-up, but treatment is not required unless progression i...
6
77
251